GlassScriptPhysician profile
Natalia Danelich
NPI 1841705795
$8,699.45
in general payments reported to CMS, 2019-2025
18 companies · $1,848 in 2025
The $1,848 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $877 · 2022: $1,387 · 2023: $2,342 · 2024: $2,245 · 2025: $1,848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,026 · Consulting Fee: $1,295 · Travel and Lodging: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,025.55 |
| Consulting Fee | $1,295.00 |
| Travel and Lodging | $114.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,371.19 | 2021-2025 | |
| Lundbeck LLC | $1,230.28 | 2023-2025 | Vyepti |
| Pfizer INC. | $1,175.99 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $530.24 | 2021-2025 | Ajovy, Austedo Xr, Austedo |
| Lilly USA, LLC | $442.53 | 2022-2025 | Emgality, Reyvow, Kisunla |
| Biohaven Pharmaceuticals, INC. | $354.51 | 2021 | |
| Amgen INC. | $304.75 | 2021-2023 | Aimovig |
| Biohaven Pharmaceutical Holding Company LTD. | $303.63 | 2022 | |
| Impel Pharmaceuticals INC. | $253.55 | 2022-2023 | Trudhesa |
| Upsher-Smith Laboratories LLC | $227.62 | 2021-2023 | |
| Allergan, INC. | $210.91 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $114.89 | 2023 | |
| Scilex Pharmaceuticals INC. | $63.34 | 2023-2024 | Ztlido |
| Axsome Therapeutics, INC. | $29.16 | 2025 | Symbravo |
| Ipsen Biopharmaceuticals, INC | $27.24 | 2023-2024 | Dysport |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $23.37 | 2022 | |
| Biogen, INC. | $22.03 | 2021 | |
| Amneal Pharmaceuticals LLC | $14.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalia Danelich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.